Home LiteratureArticle Details
PMID: 11390623 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus.

Journal of virology ·Vol. 75 ·No. 13 ·2001-07-00 ·Pages 6204-8

Djavani M, Rodas J, Lukashevich IS, Horejsh D, Pandolfi PP, Borden KL, Salvato MS

Abstract

Lymphocytic choriomeningitis virus (LCMV) induces type I interferon (alpha and beta interferon [IFN-alpha and IFN-beta]) upon infection and yet is sensitive to the addition of type II interferon (gamma interferon [IFN-gamma]) to the culture media. This sensitivity is biologically important because it correlates inversely with the ability of certain LCMV strains to persist in mice (D. Moskophidis, M. Battegay, M. A. Bruendler, E. Laine, I. Gresser, and R. M. Zinkernagel, J. Virol. 68:1951-1955, 1994). The cellular oncoprotein PML is induced by both IFN-alpha/beta and IFN-gamma, and PML binds the LCMV Z protein and becomes redistributed within cells from nucleus to cytoplasm upon LCMV infection. In the present study, increased PML expression results in diminished LCMV replication, implicating PML in the IFN sensitivity of LCMV. Virus production in PML -/- murine embryonic fibroblasts (MEF) exceeds virus production in PML +/+ MEF, and this difference is exacerbated by IFN treatment that upregulates PML expression. IFN-gamma also diminishes LCMV production in PML -/- cells; therefore, viral IFN sensitivity is not entirely due to PML. Both viral mRNA production and viral protein production decrease as PML expression increases. Here we propose that PML reduces LCMV transcription through its interaction with the Z protein.

MeSH Terms
Animals Carrier Proteins/metabolism Cell Division/drug effects Interferons/pharmacology Intracellular Signaling Peptides and Proteins Lymphocytic choriomeningitis virus/drug effects Mice Neoplasm Proteins/physiology Nuclear Proteins Promyelocytic Leukemia Protein RNA, Messenger/analysis RNA, Viral/analysis Transcription Factors/physiology Tumor Suppressor Proteins Viral Proteins/analysis,genetics Virus Replication/drug effects
Chemicals
Carrier Proteins Intracellular Signaling Peptides and Proteins Neoplasm Proteins Nuclear Proteins Pml protein, mouse Promyelocytic Leukemia Protein RNA, Messenger RNA, Viral Transcription Factors Tumor Suppressor Proteins Viral Proteins p11 Z protein, Lymphocytic choriomeningitis virus Interferons
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Djavani M
Institute of Human Virology, University of Maryland Biotechnology Center, 725 W. Lombard St., Baltimore, MD 21201, USA.
Rodas J
Lukashevich I S
Horejsh D
Pandolfi P P
Borden K L
Salvato M S
References (20)
20 references, click to expand
  1. Interferons and their actions.
    Annu Rev Biochem. 1987;56:727-77 PMID: 2441659
  2. Distinctive RNA transcriptase, polyadenylic acid polymerase, and polyuridylic acid polymerase activities associated with Pichinde virus.
    J Virol. 1979 Apr;30(1):98-107 PMID: 225533
  3. Reassessing the hemostatic disorder associated with acute promyelocytic leukemia.
    Blood. 1992 Feb 1;79(3):543-53 PMID: 1732003
  4. The Tacaribe arenavirus small zinc finger protein is required for both mRNA synthesis and genome replication.
    J Virol. 1993 Feb;67(2):807-12 PMID: 8419647
  5. Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon.
    J Virol. 1994 Mar;68(3):1951-5 PMID: 8107255
  6. The PML growth-suppressor has an altered expression in human oncogenesis.
    Oncogene. 1995 Apr 6;10(7):1315-24 PMID: 7731682
  7. The acute promyelocytic leukaemia-associated PML gene is induced by interferon.
    Oncogene. 1995 Sep 7;11(5):871-6 PMID: 7545807
  8. Induction of the PML protein by interferons in normal and APL cells.
    Leukemia. 1995 Dec;9(12):2027-33 PMID: 8609713
  9. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element.
    Oncogene. 1995 Dec 21;11(12):2565-73 PMID: 8545113
  10. Completion of the Lassa fever virus sequence and identification of a RING finger open reading frame at the L RNA 5' End.
    Virology. 1997 Sep 1;235(2):414-8 PMID: 9281522
  11. The promyelocytic leukemia protein PML has a pro-apoptotic activity mediated through its RING domain.
    FEBS Lett. 1997 Nov 24;418(1-2):30-4 PMID: 9414089
  12. An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm.
    J Virol. 1998 Jan;72(1):758-66 PMID: 9420283
  13. Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein.
    J Virol. 1998 Feb;72(2):1043-51 PMID: 9444998
  14. Role of PML in cell growth and the retinoic acid pathway.
    Science. 1998 Mar 6;279(5356):1547-51 PMID: 9488655
  15. Two RING finger proteins, the oncoprotein PML and the arenavirus Z protein, colocalize with the nuclear fraction of the ribosomal P proteins.
    J Virol. 1998 May;72(5):3819-26 PMID: 9557665
  16. Cellular factors in the transcription and replication of viral RNA genomes: a parallel to DNA-dependent RNA transcription.
    Virology. 1998 Apr 25;244(1):1-12 PMID: 9581772
  17. A role for PML and the nuclear body in genomic stability.
    Oncogene. 1999 Dec 23;18(56):7941-7 PMID: 10637504
  18. The lymphocytic choriomeningitis virus RING protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a RING-dependent manner.
    J Virol. 2000 Apr;74(7):3293-300 PMID: 10708446
  19. Interactions between viruses and lymphocytes. I. In vivo replication of lymphocytic choriomeningitis virus in mononuclear cells during both chronic and acute viral infections.
    J Immunol. 1978 Oct;121(4):1262-9 PMID: 308960
  20. Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities.
    Virology. 1991 Jul;183(1):1-11 PMID: 1711253
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2001-07-00
Pages
6204-8
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC114337
Subset
IM
Grants
NIAID NIH HHS · R01 AI032107 · United States
NIAID NIH HHS · AI 32107 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com